Detectable Material Placed In Body Patents (Class 600/431)
-
Patent number: 8848861Abstract: A system acquires images in the presence of a contrast agent of relatively long persistence using a synchronization processor, image acquisition device and imaging controller. The synchronization processor provides an image acquisition trigger signal for acquiring images at a particular point within both a cardiac and a respiratory cycle in response to signals representing cardiac and respiratory cycles. The image acquisition device includes an assembly comprising a radiation emitter and detector rotatable about a patient for acquiring images of a portion of patient anatomy at different angles. The imaging controller initiates acquisition of data representing multiple images in the presence of a contrast agent of relatively long persistence by repetitively, initiating rotation of the assembly to an angle, acquiring an image at the angle in response to the trigger signal and incrementally increasing the angle.Type: GrantFiled: May 31, 2012Date of Patent: September 30, 2014Assignees: Siemens Aktiengesellschaft, Siemens Medical Solutions USA, Inc.Inventors: Andrew F Hall, Jan Boese
-
Publication number: 20140288412Abstract: Systems and methods are disclosed for locating the parathyroid. In one aspect, temporal variation among a plurality of images is evaluated and at least one image is enhanced according to the temporal variation. The image may be enhanced to one or both of reduce conspicuity of the thyroid gland and enhance conspicuity of the parathyroid gland. Some of the plurality of images may be adjusted in order to align representations of a target portions. Adjustments may be based locations of one or more organs or one or more artificial markers affixed to a living body in the plurality of images. A local positioning system (LPS), GPS, or other locating system may be used to position a living body, align the plurality of images, or to guide the positioning of objects relative to the living body. An elastomeric gel marker for imaging applications is also disclosed.Type: ApplicationFiled: May 17, 2013Publication date: September 25, 2014Inventor: Alan N. Schwartz
-
Publication number: 20140288421Abstract: Provided are ultrasound imaging methods that include administering to a subject a contrast agent that includes a plurality of collapsible gas vesicles, obtaining ultrasound data of a target site of interest, and analyzing the ultrasound data to produce an ultrasound image of the target site. Ultrasound contrast agents are also provided. The subject methods and contrast agents find use in ultrasound imaging applications.Type: ApplicationFiled: March 12, 2014Publication date: September 25, 2014Inventors: Mikhail Georgievich Shapiro, Patrick William Goodwill, David Vernon Schaffer, Steven Michael Conolly
-
Publication number: 20140276035Abstract: A sensitive method of assessing treatment using molecular and anatomical imaging scans provides automatic tumor identification and quantification within anatomical zones based on treatment criteria. Absolute or comparative measures of tumors in pre- and/or post-scans are thereby isolated from other tissue to accentuate the progress of the treatment when multiple scattered disease lesions are present.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATIONInventors: ROBERT JERAJ, GLENN LIU
-
Publication number: 20140276033Abstract: An ablation system including an image database storing a plurality of computed tomography (CT) images of a luminal network and a navigation system enabling, in combination with an endoscope and the CT images, navigation of a locatable guide and an extended working channel to a point of interest. The system further includes one or more fiducial markers, placed in proximity to the point of interest and a percutaneous microwave ablation device for applying energy to the point of interest.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Applicant: COVIDIEN LPInventors: Joseph D. Brannan, Casey M. Ladtkow, Darion R. Peterson, Eric W. Larson, William J. Dickhans, Richard A. Willyard, Jason A. Case
-
Publication number: 20140276038Abstract: The invention generally relates to systems and methods for predicting impact of a catheter on curvature of a vessel. In certain aspects, the invention provides a system for predicting impact of a catheter on curvature of a vessel. The system includes a central processing unit (CPU) and storage coupled to the CPU for storing instructions. The stored instructions, when executed by the CPU, cause the CPU to accept as input data representative of stiffness of a catheter. The CPU is additionally caused to compare the data to a material parameters data set. The material parameters data set includes vessel displacement values for catheters of different stiffness. The CPU is additionally caused to predict impact of the catheter on a curvature of a vessel based on the comparison of the data to the material parameters data set, and to provide the prediction as an output.Type: ApplicationFiled: March 13, 2014Publication date: September 18, 2014Applicant: VOLCANO CORPORATIONInventors: Joseph Burnett, K. Matthews, Neil Hattangadi, Scott Huennekens, Bret Millett
-
Publication number: 20140276021Abstract: The present invention provides particulate contrast media for use in CT imaging. The contrast media are based on particles of low-Z elements. In an exemplary embodiment, the invention provides an enteric contrast medium formulation. An exemplary formulation comprises, (a) an enteric contrast medium comprising essentially water-insoluble particles of a material selected from microparticles and nanoparticles. Exemplary particles comprise a material comprising a plurality of atoms of an element with an atomic number from 6 to 52. In various embodiments, the particles are coated with a material compatible with enteric administration of the formulation to a subject in need of such administration. In an exemplary embodiment, the contrast medium is incorporated into a pharmaceutically acceptable vehicle in which the particles are suspended.Type: ApplicationFiled: March 17, 2014Publication date: September 18, 2014Inventors: Benjamin M. YEH, Yanjun FU, Tejal DESAI
-
Publication number: 20140276037Abstract: A marker delivery device comprises a marker deployer cannula, a push rod, a biopsy site marker, and a ramped tip. The marker deployer cannula may have a marker exit in communication with an interior lumen of the cannula. The marker exit may comprise a distal end with a ramped surface. The biopsy site marker may be configured with a plurality of edges. The plurality of edges may be configured to engage at least a portion of the interior lumen of the cannula. The ramped tip may comprise a first ramped surface and a second ramped surface, the second ramped surface may align with the ramped surface of the distal end of the marker exit. The push rod may be used to push the biopsy site marker up the ramped tip and through the marker exit.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Applicant: Devicor Medical Products, Inc.Inventors: Michael E. Johnson, Timothy Zimmer, Alberto Cambero Rangel
-
Publication number: 20140276007Abstract: A medical navigation system having a surgical pointer is provided. The surgical pointer is used in the medical navigation system. The surgical pointer comprises an external sheath and an internal tool having a proximal end and a distal end. The internal tool is contained at least partially within the external sheath. The internal tool has a tip at the distal end that extends beyond the external sheath. The tip engages a surface of a patient. The internal tool further has a tracking marker trackable by the navigation system. The surgical pointer further has a linking component contained at least partially within the external sheath and interfacing with the internal tool. The linking component is configured to control pressure exerted by the tip on the surface of the patient.Type: ApplicationFiled: March 17, 2014Publication date: September 18, 2014Inventors: Gal Sela, Cameron Piron, Joshua Richmond
-
Publication number: 20140275977Abstract: Systems and methods for visualizing fluid enhanced ablation therapy are described herein. In one embodiment, a method for ablating tissue is provided that includes inserting an elongate body into a tissue volume, heating an imageable fluid within the elongate body to transform the imageable fluid into an imageable therapeutic fluid, delivering the imageable therapeutic fluid into the tissue volume to deliver a therapeutic dose of thermal energy to the tissue volume, and imaging the tissue volume to determine the extent of the tissue volume containing the imageable therapeutic fluid. The imageable therapeutic fluid can indicate the extent of the tissue volume that has received the therapeutic dose of thermal energy.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Inventors: Michael G. Curley, Gregory R. Eberl, Douglas L. Packer, Malini Madhavan
-
Publication number: 20140276032Abstract: A dual modality probe is disclosed having both a gamma probe sensor and an ultrasound sensor. A dual imaging system is provided having the probe and at least one external gamma imaging detector and a data acquisition computer system for collecting data simultaneously from the gamma probe sensor, the gamma imaging detector, and the ultrasound sensor of the probe. A method for evaluating a target organ of a patient utilizing the probe and imaging system, and performing a biopsy of the organ is disclosed.Type: ApplicationFiled: March 14, 2013Publication date: September 18, 2014Inventors: Stanislaw Majewski, Gary Marano, Alexander Stolin, James Proffitt
-
Publication number: 20140276036Abstract: The invention provides systems and methods for assessing the vasculature of a subject. In certain aspects, systems and methods of the invention involve receiving functional flow data of a subject via a data collector co-located with a radiopaque label, receiving imaging data of the vasculature including the radiopaque label, generating a vasculature map corresponding to the functional flow data, and displaying the vasculature map image on a monitor.Type: ApplicationFiled: March 11, 2014Publication date: September 18, 2014Applicant: VOLCANO CORPORATIONInventors: Donna Collins, Mary Lynn Gaddis, Nathaniel J. Kemp, Bernhard Sturm
-
Publication number: 20140276034Abstract: A system, and apparatus for detecting and quantifying circulatory anomalies, including right-to-left cardiac shunts. The apparatus implements a sensor system useful in connection with a circulatory indicator delivery system. The sensor apparatus is preferably configured with a series of emitter/detector pairs to optimize the sensitivity of detection of the circulating indicator. Sensing of the indicator concentration takes place at an arterial vasculature, for example, the pinna of the human ear. A monitor/controller calculates and displays a indicator/dye dilution curve to assess for the presence of a cardiac shunt. The monitor/controller further corrects the indicator/dilution curve displayed for any recirculation phenomena and can quantify any right-to-left shunt calculated conductance associated with detected shunts.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Applicant: Cardiox CorporationInventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers
-
Patent number: 8838208Abstract: Embodiments include a fiducial deployment system. A fiducial may include dimples to enhance echogenicity and/or to provide for engagement with a delivery cannula or stylet. The needle system may be configured to deliver a plurality of fiducials to a target location in serial fashion, one at a time, when the fiducials are coaxially disposed around a central deployment member that may be embodied as a delivery cannula or stylet. In certain embodiments, echogenic placement of fiducials may present certain advantages. An elongate structure may be included that is configured to distally advance fiducials along the deployment member.Type: GrantFiled: June 18, 2012Date of Patent: September 16, 2014Assignee: Cook Medical Technologies LLCInventors: Shay Lavelle, Paul Devereux, Michael Clancy
-
Publication number: 20140257096Abstract: In Positron Emission Tomography, a time window (260) and an energy window (225) are dynamically adjusted, based on an attenuation map, count rate, clinical application, discrimination tailoring, and/or offline discrimination tailoring. Detected radiation events are filtered using the dynamically adjusted energy and time windows into scattered events, random events, and true events. The true events are input to image reconstruction, correction, and error analysis.Type: ApplicationFiled: October 3, 2012Publication date: September 11, 2014Applicant: KONINKLIJKE PHILIPS N.V.Inventors: Sven Prevrhal, Eberhard Sebastian Hansis, Jason Stephen Wiener, Joerg Bredno, David Sowards-Emmerd, Lingxiong Shao
-
Publication number: 20140255314Abstract: The present invention relates to a method of regulating or inducing specific physiological conditions or functions using one or more materials displayed on a nano-assembly matrix at high density in cells or in vivo. Specifically, the present invention relates to a method of effectively inducing specific physiological regulation in cells or in vivo by the high-density display of bioactive materials. According to the method of the invention, physiological regulation in cells or in vivo can be optionally induced by regulating the assembly and disassembly of nano assembly (unit) matrix or the display or trapping of specific materials on nano assembly (unit) matrix.Type: ApplicationFiled: August 10, 2012Publication date: September 11, 2014Inventor: Tae Kook Kim
-
Publication number: 20140257094Abstract: A perfusion analysis system includes a perfusion modeller and a user interface. The perfusion modeller generates a patient specific perfusion model based on medical imaging perfusion data for the patient, a general perfusion model, and a quantification of one or more identified pathologies of the patient that affect perfusion in the patient. The user interface accepts an input indicative of a modification to the quantification of the one or more identified pathologies. In response, the perfusion modeller updates the patient specific perfusion model based on the medical imaging perfusion data for the patient, the general perfusion model, and the quantification of the one or more identified pathologies of the patient, including the modification thereto.Type: ApplicationFiled: May 22, 2014Publication date: September 11, 2014Applicant: KONINKLIJKE PHILIPS N.V.Inventors: Kirsten MEETZ, Ingwer CARLSEN, Heinrich SCHULZ, Rafael WIEMKER, Stewart YOUNG
-
Publication number: 20140249399Abstract: A method for determining functional severity of a stenosis includes: (a) generating a simulated perfusion map from a calculated blood flow; (b) comparing the simulated perfusion map to a measured perfusion map to identify a degree of mismatch therebetween, the measured perfusion map representing perfusion in a patient; (c) modifying a parameter in a model used in calculating the blood flow when the degree of mismatch meets or exceeds a predefined threshold; (d) computing a hemodynamic quantity from the simulated perfusion map when the degree of mismatch is less than the predefined threshold, the hemodynamic quantity being indicative of the functional severity of the stenosis; and (e) displaying the hemodynamic quantity. Systems for determining functional severity of a stenosis are described.Type: ApplicationFiled: February 14, 2014Publication date: September 4, 2014Applicant: Siemens AktiengesellschaftInventors: Puneet Sharma, Ali Kamen, Max Schöbinger, Michael Scheuering, Dorin Comaniciu
-
Publication number: 20140249409Abstract: A lead includes a lead body having at least two electrodes and a lead marker. The lead marker corresponds to a size and spacing of each of the at least two electrodes. The spacing between the electrodes and lead marker corresponds to an operative length of a first lead introducer configured to be used with the lead. Lead systems that include one or more lead introducers and kits including the same are also disclosed.Type: ApplicationFiled: May 16, 2014Publication date: September 4, 2014Applicant: Medtronic, Inc.Inventor: Carole A. Tronnes
-
Publication number: 20140249391Abstract: Methods for distinguishing between two interspersed biological tissues, for procedures such as surgical resection, include exposing the tissues to at least two components, a first of which components produces or is capable of producing a detectable signal, and the other of which components either blocks the produced signal of the first component or activates the first component to produce the detectable signal. One of the components is selectively taken up by one of the tissues at a concentration which is greater than the concentration by which it is taken up by the other tissue to provide a distinguishable difference in the detectable signal originating from the two tissues.Type: ApplicationFiled: April 23, 2012Publication date: September 4, 2014Applicant: EMPIRE TECHNOLOGY DEVELOPMENT LLCInventor: Christopher J. Rothfuss
-
Publication number: 20140248213Abstract: The present invention provides for heptamethine cyanine dyes that possess both nuclear and near-infrared imaging capabilities. These dyes can be used for imaging, targeting and detecting tumors in patients.Type: ApplicationFiled: October 5, 2012Publication date: September 4, 2014Applicants: CEDARS-SINAI MEDICAL CENTER, UNIVERSITY OF VIRGINIA PATENT FOUNDATIONInventors: Leland W. K. Chung, Dongfeng Pan
-
Patent number: 8825139Abstract: A method for automatic detection of a contrast agent inflow in a blood vessel of a patient with a CT system, and CT system for carrying out this method, are disclosed. At least one embodiment of the invention relates to a method which determines the position of at least one blood vessel in section image representations in a CT examination without external intervention with the aid of an active shape or active appearance model, measures the inflow of contrast agent in this region in a targeted way and automatically initiates at least one action in the event of inflowing contrast agent.Type: GrantFiled: April 25, 2011Date of Patent: September 2, 2014Assignee: Siemens AktiengesellschaftInventors: Dominik Bernhardt, Ute Feuerlein, Stefan Groβkopf, Michael Scheuering
-
Patent number: 8825131Abstract: An MR Spectroscopy (MRS) system and approach is provided for diagnosing painful and non-painful discs in chronic, severe low back pain patients (DDD-MRS). A DDD-MRS pulse sequence generates and acquires DDD-MRS spectra within intervertebral disc nuclei for later signal processing and diagnostic analysis. An interfacing DDD-MRS signal processor receives output signals of the DDD-MRS spectra acquired and is configured to optimize signal-to-noise ratio by an automated system that selectively conducts optimal channel selection, phase and frequency correction, and frame editing as appropriate for a given acquisition series. A diagnostic processor calculates a diagnostic value for the disc based upon a weighted factor set of criteria that uses MRS data extracted from the acquired and processed MRS spectra for multiple chemicals that have been correlated to painful vs. non-painful discs. A display provides an indication of results for analyzed discs as an overlay onto a MRI image of the lumbar spine.Type: GrantFiled: April 11, 2012Date of Patent: September 2, 2014Assignee: NOCIMED, LLCInventors: James Clayton Peacock, III, John Patrick Claude, Paul Henry Kane
-
Publication number: 20140243664Abstract: Provided herein are nanobubbles designed for use in ultrasound-mediated ablation of cancer cells. The nanobubbles undergo ultrasound-mediated cavitation at an ablation threshold which is significantly decreased, relative to standard ultrasound-mediated treatment of cancer cells. In exemplary embodiments, the nanobubbles comprise an amphiphilic ABC triblock copolymer, wherein block A comprises a hydrophilic polymer, block B comprises a crosslinking polymer, and block C comprises a hydrophobic copolymer comprising (i) methyl methacrylate (MMA) and (ii) a fluorinated monomer, wherein the fluorinated monomer is present in the hydrophobic copolymer of block C at 25 mole percent or less. Related treatment and diagnostic methods, as well as materials relating to the nanobubbles are provided herein. Methods of making a random copolymer are furthermore provided herein.Type: ApplicationFiled: October 10, 2012Publication date: August 28, 2014Inventors: Mohamed El-Sayed, Yasemin Yuksel Durmaz
-
Publication number: 20140236005Abstract: A method of imaging a blood vessel includes delivering a bubble-based contrast agent within the vessel and positioning at least one ultrasound device in the vicinity of the bubble-based contrast agent within the vessel. A first burst of low-frequency ultrasound energy can be delivered to excite the bubble-based contrast agent into oscillation within the vessel, and a second burst of high-frequency ultrasound energy can be delivered at the excited bubble-based contrast agent. A return signal from the burst of high-frequency ultrasound energy can be received and processed to obtain one or more images.Type: ApplicationFiled: August 24, 2012Publication date: August 21, 2014Applicant: University of Pittsburgh-Of the Commonwealth Systems of Higher EducationInventors: Xucai Chen, Francois T.H. Yu, Flordeliza S. Villanueva
-
Publication number: 20140236004Abstract: A tissue response in a predetermined unit of volume or area tissue of interest is determined by excluding some data of the adjacent tissues based upon a blood flow direction with respect to the tissue of interest. The exclusion is based upon a predetermined time-related parameter such as time-to-peak and mean-transit time in the fitted curves of the uptake of a contrast agent in the adjacent tissues and the tissue of interest. Furthermore, the blood flow direction is determined in terms of a 3D vector based upon a plurality of weighted individual vectors from the adjacent or neighboring voxels with respect to the voxel of interest.Type: ApplicationFiled: February 19, 2013Publication date: August 21, 2014Applicants: TOSHIBA MEDICAL SYSTEMS CORPORATION, KABUSHIKI KAISHA TOSHIBAInventor: Nicolas ROGNIN
-
Publication number: 20140228682Abstract: Embodiments of the present disclosure include methods of imaging a target area, methods of monitoring the degeneration of cartilage, and the like.Type: ApplicationFiled: February 5, 2014Publication date: August 14, 2014Inventors: Hongguang Liu, Xiang Hu, Zhen Cheng, Yang Liu
-
Publication number: 20140228674Abstract: A method for increasing the temporal fidelity, increasing the temporal sampling density, and/or reducing the temporal noise of a series of image frames obtained with a medical imaging system is provided. The image frames are acquired with the medical imaging system. The medical imaging system may be, for example, an x-ray C-arm imaging system. A window function that is representative of a temporal fidelity window is selected and used to temporally deconvolve the image frames using a minimization technique. A temporal sampling density may also be selected and used in the temporal deconvolution. The resultant deconvolved image frames have a higher temporal fidelity to a time-varying image contrast depicted in the acquired image frames, and may also have an increased temporal sampling density and/or reduced temporal noise.Type: ApplicationFiled: February 8, 2013Publication date: August 14, 2014Inventors: Guang-Hong Chen, Jie Tang
-
Patent number: 8805478Abstract: Methods of performing a power injection procedure are described. One method includes taking an x-ray of a subcutaneously implanted access port in a patient to determine whether the access port includes a radiographic feature indicating that the access port is suitable for flowing fluid at a rate of at least about 1 milliliter per second through the access port, identifying the indicating radiographic feature on the x-ray, and flowing a fluid through the access port at a rate of at least about 1 milliliter per second.Type: GrantFiled: April 7, 2009Date of Patent: August 12, 2014Assignee: C. R. Bard, Inc.Inventors: Kelly B. Powers, Jim C. Beasley, Kevin W. Sheetz, Jay Gerondale, Guy Rome
-
Publication number: 20140221828Abstract: Medical devices include echogenic subregions and echolucent subregions arranged in an alternating pattern and having exogenous features. Examples include metal printing and cast metal being applied to a plastic structure. Other examples include a fluid contrast agent including microbubbles housed in compartments within a structure. Additional examples include small resonators built into a structure for resonating at a specific frequency and imageable with a harmonic imaging mode of an ultrasound imaging system.Type: ApplicationFiled: February 3, 2014Publication date: August 7, 2014Inventors: PETER S. MCKINNIS, YUN ZHOU, NEAL E. FEARNOT
-
Publication number: 20140221830Abstract: Thermochemical ablation techniques may provide ablation of bodily tissue using chemical reaction energy.Type: ApplicationFiled: April 14, 2014Publication date: August 7, 2014Applicant: Regents of the University of MinnesotaInventor: Erik N.K. Cressman
-
Publication number: 20140221829Abstract: Methods and systems for whole body optical imaging using localized fluorescence excitation.Type: ApplicationFiled: February 3, 2014Publication date: August 7, 2014Applicant: THE TEXAS A&M UNIVERSITY SYSTEMInventors: Kristen Carlson Maitland, Jeffrey D. Cirillo, Ying Kong, Joel N. Bixler
-
Patent number: 8798717Abstract: A patient support and/or transport device is proposed. The patient support and/or transport device comprises a receptacle in particular for a push-in patient support plate. At least one metal detection device is provided on the receptacle adjacent to the patient support plate when the patient support plate is pushed in.Type: GrantFiled: June 29, 2010Date of Patent: August 5, 2014Assignee: Siemens AktiengesellschaftInventor: Bjarne Erik Roscher
-
Publication number: 20140213898Abstract: A method for detecting fluid injection in a patient, the method including the steps of providing a fluid storage tank; providing fluid for use in machinery and adding said fluid to the fluid storage tank; and providing a fluorescent dye and adding the fluorescent dye to the fluid such that the fluid fluoresces in the presence of ultraviolet light.Type: ApplicationFiled: February 2, 2012Publication date: July 31, 2014Applicant: TTAAS Thommo's Training & Assessment Systems Pty LtdInventor: Wayne Thompson
-
Patent number: 8792966Abstract: Methods and devices are provided for marking tissue to be subsequently located for removal from a body or for other examination. In general, a marker is provided that can be delivered through a tissue wall proximate to tissue desirable for marking. The marker can be movable between a non-deployed or unexpanded position, in which the marker is configured to be delivered through a relatively small diameter passageway, to an expanded, balloon-like position in which the marker is configured to engage opposed sides of a tissue wall proximate to the desired tissue. The marker can remain disposed in the body in its expanded position and be subsequently palpably identified and/or visually identified to locate the desired tissue.Type: GrantFiled: March 3, 2008Date of Patent: July 29, 2014Assignee: Ethicon Endo-Surgery, Inc.Inventors: James W. Voegele, William B. Weisenburgh, II
-
Publication number: 20140206984Abstract: A method for implanting a cardiac support device (CSD) on a patient's heart. An amount of contrast agent sufficient to cause structures on the heart to be visible upon fluoroscopic or other imaging is introduced into the pericardial space surrounding the heart. The heart and contrast agent are imaged to provide a visual indication of the location of the structures of the heart. The CSD is placed on the heart using the visual indications provided by the imaging.Type: ApplicationFiled: March 24, 2014Publication date: July 24, 2014Applicant: MARDIL, INC.Inventors: William E. COHN, Aaron J. HJELLE, Robert G. WALSH, Kevin Paul Bassett
-
Publication number: 20140206992Abstract: Methods for identifying the presence of cancerous cells or tissue by: applying a compound of formula (I), or salts thereof, to a living body, wherein R1 represents hydrogen or the same or different one to four substituents; R2, R3, R4, R5, R6, and R7 independently represent hydrogen, hydroxy, alkyl, or halogen; R8 and R9 independently represent hydrogen or alkyl; and X represents C1-C3 alkylene; and detecting fluorescence emitted by a compound of formula (II), wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are as defined above; wherein fluorescence emitted by a compound of formula (II) is indicative of the presence of cancerous cells or tissue.Type: ApplicationFiled: January 24, 2014Publication date: July 24, 2014Applicant: THE UNIVERSITY OF TOKYOInventors: Yasuteru URANO, Tetsuo NAGANO, Masayo SAKABE
-
Publication number: 20140206991Abstract: A method is disclosed for the prediction of a likely contrast medium behavior for a contrast medium-assisted examination of an object under investigation. In an embodiment, the method includes detecting patient-specific blood flow behavior data in a pre-measurement making use of a defined examination protocol and determining an individual impulse response function from the blood flow behavior data; detecting a pre-measured heart rate signal associated with the pre-measurement; and predicting the likely contrast medium behavior based on the individual impulse response function, the pre-measured heart rate signal and a current examination protocol, and a currently detected heart rate signal. A method for activation of a medical imaging system is also disclosed. Also disclosed are a device for predicting a likely contrast medium behavior, a control device with a device of this type for an imaging system, and an imaging system with a control device.Type: ApplicationFiled: January 8, 2014Publication date: July 24, 2014Applicant: SIEMENS AKTIENGESELLSCHAFTInventor: Johannes Georg KORPORAAL
-
Publication number: 20140206987Abstract: This disclosure describes embodiments of a kit and its constituent components which together form an apparatus in which fluid communication between a medical device's lumen and the surrounding environment is provided by a conduit cooperatively defined by the medical device and a tubular member into which the device is inserted. The medical device and tubular member are configured to fit together such that an outer surface of the distal region of the medical device cooperates with an inner surface of the tubular member to define the conduit between the side-port of the medical device and a distal end of the tubular member. The conduit is operable to be used for injecting fluid, withdrawing fluid, and measuring pressure, for example. Methods of assembling and using the apparatus are described as well.Type: ApplicationFiled: March 24, 2014Publication date: July 24, 2014Applicant: Baylis Medical Company Inc.Inventors: John Paul Urbanski, Krishan Shah, Gareth Davies, Mahmood Mirza, Naheed Visram, Amanda Hartley
-
Patent number: 8787643Abstract: A method includes generating a kinetic parameter value for a VOI in a functional image of a subject based on motion corrected projection data using an iterative algorithm, including determining a motion correction for projection data corresponding to the VOI based on the VOI, motion correcting the projection data corresponding to the VOI to generate the motion corrected projection data, and estimating the at least one kinetic parameter value based on the motion corrected projection data or image data generated with the motion corrected projection data. In another embodiment, a method includes registering functional image data indicative of tracer uptake in a scanned patient with image data from a different imaging modality, identifying a VOI in the image based on the registered images, generating at least one kinetic parameter for the VOI, and generating a feature vector including the at least one generated kinetic parameter and at least one bio-marker.Type: GrantFiled: January 12, 2010Date of Patent: July 22, 2014Assignee: Koninklijke Philips B.V.Inventors: Manoj V. Narayanan, Jens-Christoph Georgi, Frank O. Thiele, Ralph Brinks, Michael Perkuhn
-
Patent number: 8784433Abstract: An intracorporeal marker delivery device includes a delivery tube which has a distal tip, a discharge orifice and an inner bore extending to the discharge orifice. A plug is releasably secured within the inner bore. The plug may itself serve as a marker, and may be the sole marker. Markers may be positioned proximal to the plug, and may be detectable by ultrasound, X-ray, magnetic resonance imaging, and other imaging devices, and may include bioactive elements.Type: GrantFiled: April 27, 2012Date of Patent: July 22, 2014Assignee: SenoRx, Inc.Inventors: Paul Lubock, Jason H. Safabash, Martin Shabaz, John Merritt
-
Publication number: 20140200447Abstract: Apparatus for radiation based imaging of a non-homogenous target area having distinguishable regions therein, comprises: an imaging unit configured to obtain radiation intensity data from a target region in the spatial dimensions and at least one other dimension, and an image four-dimension analysis unit analyzes the intensity data in the spatial dimension and said at least one other dimension in order to map the distinguishable regions. The system typically detects rates of change over time in signals from radiopharmaceuticals and uses the rates of change to identify the tissues. In a preferred embodiment, two or more radiopharmaceuticals are used, the results of one being used as a constraint on the other.Type: ApplicationFiled: March 16, 2014Publication date: July 17, 2014Applicant: Biosensors International Group, Ltd.Inventors: Benny Rousso, Michael Nagler
-
Publication number: 20140194736Abstract: A system for facilitating imaging of an anatomical structure(s) can be provided, and can include, for example, a substance which can induce a change in the anatomical structure(s) when applied to the anatomical structure(s), and an imaging arrangement which can be configured to generate an image of the anatomical structure(s) based on the change of the anatomical structure(s) when the substance is applied. The imaging arrangement can include an apparatus which can be configured to (i) illuminate the anatomical structure(s) with a first electro-magnetic radiation(s), and (ii) receive a second electro-magnetic radiation from the anatomical structure(s) that can be based on the first electro-magnetic radiation. The change can affect a characteristic(s) of the second electro-magnetic radiation.Type: ApplicationFiled: January 3, 2014Publication date: July 10, 2014Applicant: THE GENERAL HOSPITAL CORPORATIONInventors: Guillermo J. Tearney, Tao Wu, Dongkyun Kang, Melissa J. Suter
-
Publication number: 20140193336Abstract: Protocols for radioimaging an event or disorder are provided. An exemplary protocol comprises a method of radioimaging a myocardial perfusion, the method comprising in sequence: (a) administering to a subject about 3 mCi Tl201 thallous chloride; (b) allowing said subject to rest; (c) radioimaging a heart of said subject; (d) subjecting said subject to a physical stress; (e) administering to said subject at a peak of said physical stress about 20-30 mCi Tc99m sestamibi; and (f) radioimaging said heart of said subject, thereby radioimaging a myocardial perfusion.Type: ApplicationFiled: January 6, 2014Publication date: July 10, 2014Applicant: Biosensors International Group, Ltd.Inventors: Benny ROUSSO, Dalia Dickman, Yael Nir, Michael Nagler, Zohar Bronshtine, Shankar Vallabhajosula, Shlomo Ben-Haim, Simona Ben-Haim
-
Publication number: 20140193907Abstract: Described here are devices and methods for the delivery of molecules, including biologically active molecules, into tissues. The devices and methods are generally particle based, and devised to deploy the molecules into a target tissue in a controlled manner to minimize tissue damage. The devices and methods may further be devised to tailor molecule delivery parameters to a variety of tissue types. Kits including various device components are also described.Type: ApplicationFiled: December 12, 2013Publication date: July 10, 2014Applicant: Bay Genomics, LLCInventors: Kenneth GREENBERG, Scott GELLER
-
Publication number: 20140187932Abstract: A CT imaging method and a CT system based on a multi-mode scout scan. The CT imaging method based on a multi-mode scout scan comprises: performing an instant switching dual energy scout radiation scan on a region of interest of a subject by way of instant switching between high voltage and low voltage to collect dual energy protection data of the region of interest; and reconstructing a material decomposition image and a mono-energetic image based on the collected dual energy projection data.Type: ApplicationFiled: December 20, 2013Publication date: July 3, 2014Applicant: GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLCInventors: YING LI, Yusi CHEN, JING ZHAO, DONG WEI
-
Publication number: 20140187928Abstract: An embodiment in accordance with the present invention provides a method for non-invasively determining the functional severity of coronary artery stenosis. The method includes gathering patient-specific data related to concentration of a contrast agent within a coronary artery of a patient using a coronary computed tomography angiography scan (CCTA). The patient-specific data is used to calculate a patient-specific transluminal attenuation gradient for the coronary artery of the patient. The patient specific transluminal attenuation gradient is used to determine an estimate of a coronary flow velocity, pressure gradient, loss coefficient, coronary flow reserve, and/or fractional flow reserve for the patient. Coronary flow velocity, pressure gradient, loss coefficient, coronary flow reserve, and fractional flow reserve can then be used to estimate the functional severity of coronary artery stenosis.Type: ApplicationFiled: February 25, 2014Publication date: July 3, 2014Applicant: The Johns Hopkins UniversityInventors: Rajat Mittal, Albert C. Lardo, Jung Hee Seo
-
Publication number: 20140187927Abstract: A method for predefining a set of radioactive-emission measurement views, for radioactive-emission imaging after an administration of a radiopharmaceutical, the method being tailored to a specific body structure and optimized with respect to the information gained about the body structure and based on modeling body-structure, based on its geometry and anatomical constraints, which limit accessibility to the body structure.Type: ApplicationFiled: December 26, 2013Publication date: July 3, 2014Applicant: Biosensors International Group, Ltd.Inventors: Michael NAGLER, Eli Dichterman, Yoel Zilberstein, Ran Ravhon, Omer Ziv, Benny Rousso, Shlomo Ben-Haim
-
Publication number: 20140187931Abstract: A fluorescence imaging device detects fluorescence in parts of the visible and invisible spectrum, and projects the fluorescence image directly on the human body, as well as on a monitor, with improved sensitivity, video frame rate and depth of focus, and enhanced capabilities of detecting distribution and properties of multiple fluorophores. Direct projection of three-dimensional visible representations of florescence on three-dimensional body areas advantageously permits view of it during surgical procedures, including during cancer removal, reconstructive surgery and wound care, etc. A NIR laser and a human visible laser (HVL) are aligned coaxially and scanned over the operating field of view. When the NIR laser passes over the area where the florescent dye is present, it energizes the dye which emits at a shifted NIR frequency detected by a photo diode. The HVL is turned on when emission is detected, providing visual indication of those positions.Type: ApplicationFiled: December 5, 2013Publication date: July 3, 2014Inventors: Fred Wood, Dmitry Yavid, Joe Zott, Ron Goldman
-
Publication number: 20140180068Abstract: The present invention generally relates to methods, devices and systems for determining the rotational orientation of a device. The invention can involve providing a device comprising a plurality of markers, wherein each marker within the plurality of markers differs from an adjacent marker by size, shape, and/or position on the device. The invention can also involve inserting the device into a vessel and imaging the device to capture an image of the device in an imaging plane. The invention can further involve processing the captured image to determine an orientation of the device relative to the imaging plane based on the markers.Type: ApplicationFiled: December 19, 2013Publication date: June 26, 2014Applicant: VOLCANO CORPORATIONInventors: Jason Spencer, Russell W. Bowden, Stan Thomas, Oren Levy, Byong-Ho Park, Dietrich Ho